The Washington State Department of Health will hold a 1pm PDT June 28, 2019 meeting and webinar on the legality of the sale, delivery, and possession of specific preparations of heparin, dialysate, and KCL or NaCl for injection (“legend drugs”: see https://apps.leg.wa.gov/WAC/default.aspx?cite=246-905-020), and other drugs, by dialysis clinics. The purpose of the meeting is to discuss and clarify the kinds of licensing required by Washington State law. For details see https://content.govdelivery.com/attachments/WADOH/2019/05/23/file_attachments/1217215/20190422%20Kidney%20Dialysis%20Center%20Memo%20%28002%29.pdf.
From a meeting announcement memo: “The [Washington State] Pharmacy Commission has been asked by the [Washington] DOH Office of Health System Oversight (OHSO) for guidance on the statutory authority of ESRD or Kidney Dialysis Centers to sell, deliver, or possess legend drugs. The Pharmacy Commission and OHSO staff would like to hold a stakeholder meeting to present initial findings from the staff research and obtain input from stakeholders. Following the stakeholder meeting the Pharmacy Commission and OHSO staff will prepare an Interpretive Statement to provide guidance to the provider community and [DOH].”
To attend the meeting in person: Room 158, Town Center 2, Tumwater campus, 111 Israel Rd SE, Tumwater WA 98501. To attend the meeting by webinar, register at https://attendee.gotowebinar.com/register/9064752490396634881; further instructions will be sent to you by email. For questions or comments contact doreen.beebe@doh.wa.gov.